SC
IDXX icon

Stephens Consulting’s Idexx Laboratories IDXX Stock Holding History

Stephens Consulting’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$1.61K – 750
2025
Q2 		$1.61K Buy
+3
New +$1.44K ﹤0.01% 547
2022
Q4 		– Sell
-25
Closed -$8.14K – 527
2022
Q3 		$8.14K Hold
25
– – 0.01% 359
2022
Q2 		$8.77K Hold
25
– – 0.01% 344
2022
Q1 		$13.7K Hold
25
– – 0.01% 312
2021
Q4 		$16.5K Buy
+25
New +$15.7K 0.01% 331

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Stephens Consulting's IDXX Position: Q3 2025 in Review

Stephens Consulting sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 3 shares — an estimated $1.61K sold.

Stephens Consulting first reported a position in IDXX in Q4 2021 and held it in 5 quarters. The position peaked at $16.5K in Q4 2021. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Stephens Consulting reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Stephens Consulting sold 3 Idexx Laboratories shares in Q3 2025, an estimated $1.61K.
  • Stephens Consulting first reported a position in Idexx Laboratories in Q4 2021 and held it in 5 quarters.
  • Stephens Consulting's Idexx Laboratories position peaked at $16.5K in Q4 2021.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.